Lee Equity-backed Prelude Fertility completes Vivere Health acquisition

Prelude Fertility, which is backed by Lee Equity Partners, has closed its previously announced acquisition of Franklin, Tennessee-backed Vivere Health, which owns and operates ambulatory surgery centers and in-vitro fertilization facilities. No financial terms were disclosed. Cain Brothers provided financial advice to Vivere on the deal. Vivere Health was backed by LLR Partners.

PRESS RELEASE

Vivere Health, LLC, a portfolio company of LLR Partners and a leading operator of fertility practices and labs in partnership with physicians, was acquired by Prelude Fertility, a portfolio company of Lee Equity Partners. Cain Brothers served as the exclusive financial advisor to Vivere.

Founded in 2010 by LLR Partners and Drs. Jimmy Gill and Gus Haddad, Vivere is a leader in the $4.0 billion fertility industry. The Company partners with fertility specialists to promote or establish their practices while removing the burdens of day-to-day management. Vivere also has egg banking services and operates a mail-order pharmacy focused on fertility practices and patients throughout the U.S. The Company is headquartered in Franklin, TN and operates practices in nine markets across the country.

Prelude is a comprehensive fertility company focused on providing people with the best options for meeting their family-building goals. Founded in 2016 by serial entrepreneur Martín Varsavsky, Lee Equity Partners, Reproductive Biology Associates and MyEggBank, the company was established to give men and women more reproductive choices and greater control over their biological clocks.